Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Pharmaceutical Health Care and Sciences
|
May 19, 2026
Delayed decrease in voriconazole concentration after resolution of inflammation in a patient with invasive pulmonary aspergillosis: a case report
Haruka Igarashi, Hayato Yokota, Ayano Saito, et al.
Cureus
|
May 22, 2025
Efficacy of Switching to Levetiracetam After S-1-Induced Phenytoin Concentration Increase: A Case Report
Hayato Yokota, Haruka Igarashi, Yumiko Akamine, et al.
Biology
|
October 23, 2021
Relationship between Plasma Concentrations of Afatinib and the Onset of Diarrhea in Patients with Non-Small Cell Lung Cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 14, 2024
Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report
Hayato Yokota, Yumiko Akamine, Mizuki Kobayashi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 14, 2020
Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Clinical Lung Cancer
|
June 6, 2017
Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer
Hayato Yokota, Kazuhiro Sato, Yuji Okuda, et al.
Cancer Chemotherapy and Pharmacology
|
March 29, 2025
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2023
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Investigational New Drugs
|
September 23, 2022
Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Case Reports in Oncological Medicine
|
April 9, 2026
Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non-Small Cell Lung Cancer
Hayato Yokota, Satoshi Goshima, Yuji Okuda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Pharmaceutical Health Care and Sciences
|
May 19, 2026
Delayed decrease in voriconazole concentration after resolution of inflammation in a patient with invasive pulmonary aspergillosis: a case report
Haruka Igarashi, Hayato Yokota, Ayano Saito, et al.
Cureus
|
May 22, 2025
Efficacy of Switching to Levetiracetam After S-1-Induced Phenytoin Concentration Increase: A Case Report
Hayato Yokota, Haruka Igarashi, Yumiko Akamine, et al.
Biology
|
October 23, 2021
Relationship between Plasma Concentrations of Afatinib and the Onset of Diarrhea in Patients with Non-Small Cell Lung Cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 14, 2024
Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report
Hayato Yokota, Yumiko Akamine, Mizuki Kobayashi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 14, 2020
Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Clinical Lung Cancer
|
June 6, 2017
Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer
Hayato Yokota, Kazuhiro Sato, Yuji Okuda, et al.
Cancer Chemotherapy and Pharmacology
|
March 29, 2025
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2023
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Investigational New Drugs
|
September 23, 2022
Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, et al.
Case Reports in Oncological Medicine
|
April 9, 2026
Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non-Small Cell Lung Cancer
Hayato Yokota, Satoshi Goshima, Yuji Okuda, et al.
Page
of 2